BVS vs XLI
Bioventus Inc (BVS) versus XLI (XLI) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
XLI (XLI) common stock.
Latest reported BVS revenue for 2026-06-27 was $285.3M. Net income was $36.6M. BVS currently screens at market cap $495.1M.
XLI does not have a complete income-statement cache yet.
BVS currently screens at market cap $495.1M. XLI currently screens at market cap $0.
Not investment advice. Open the BVS and XLI stock pages for the full models.
Not investment advice.